CompaniesLeonard-Meron Biosciences

Leonard-Meron Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

144

By Phase

PHASE3: 1

By Status

UNKNOWN: 1AVAILABLE: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT02901717
Hover over trial bars to see details

Recent Trials

NCT02901717Lead Sponsor
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
PHASE3Unknown
144 participants
Started: Feb 13, 2018 · Completed: Mar 31, 2023
NCT04513821Lead Sponsor
Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
N/AAVAILABLE
Funding History (3)
D/A
Mar 10, 2015
Filing
D
Mar 10, 2015
Filing
D
Aug 12, 2014
Filing
Related Companies
Citius Pharmaceuticals
acquired